AG-1705

N/A

Report date: 2024/09/04 16:01:32

Base Information

Drug NameAG-1705
Drug Alias NameAGSAVIS-amlodipine/Valsartan/IndapamideIndapamide/Levamlodipine/ValsartanAG-1705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsSymporters inhibitorsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1SymportersVoltage-gated calcium channel
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ValsartanIndapamideLevamlodipine Gentisate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAhn-Gook Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAhn-Gook Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A